Interaction of hemoglobin vesicles, a cellular-type artificial oxygen carrier, with human plasma

Effects on coagulation, kallikrein-kinin, and complement systems

Hideki Abe, Mitsuhiro Fujihara, Hiroshi Azuma, Hisami Ikeda, Kenji Ikebuchi, Shinji Takeoka, Eishun Tsuchida, Hideyoshi Harashima

    Research output: Contribution to journalArticle

    19 Citations (Scopus)

    Abstract

    Hemoglobin vesicles (HbVs), cellular-type artificial oxygen carriers containing human hemoglobin, were assessed for their biocompatibility by mixing with human plasma in vitro. Among three kinds of HbVs (PEG-DPEA-HbV, PEG-DPPG-HbV and DPPG-HbV), PEG-DPEA-HbV did not affect the extrinsic or intrinsic coagulation activities of the plasma, while PEG-DPPG-HbV and DPPG-HbV tended to shorten the intrinsic coagulation time. The kallikrein-kinin cascade of the plasma was slightly activated by PEG-DPPG-HbV and DPPG-HbV, but not by PEG-DPEA-HbV. The complement consumption of the plasma was observed by incubation with DPPG-HbV, but not with PEG-DPEA-HbV or PEG-DPPG-HbV. These results indicate that PEG-DPEA-HbV has a higher biocompatibility with human plasma.

    Original languageEnglish
    Pages (from-to)1-10
    Number of pages10
    JournalArtificial Cells, Blood Substitutes, and Biotechnology
    Volume34
    Issue number1
    DOIs
    Publication statusPublished - 2006 Apr 1

    Fingerprint

    Kallikrein-Kinin System
    Plasma (human)
    Kinins
    Kallikreins
    Hemoglobin
    Coagulation
    Polyethylene glycols
    Hemoglobins
    Oxygen
    Biocompatibility
    Plasmas
    1,2-dipalmitoylphosphatidylglycerol

    Keywords

    • Complement
    • Hemoglobin vesicles
    • Kallikrein-Kinin
    • Liposome
    • Oxygen carrier

    ASJC Scopus subject areas

    • Biomedical Engineering
    • Hematology
    • Biotechnology
    • Biomaterials

    Cite this

    Interaction of hemoglobin vesicles, a cellular-type artificial oxygen carrier, with human plasma : Effects on coagulation, kallikrein-kinin, and complement systems. / Abe, Hideki; Fujihara, Mitsuhiro; Azuma, Hiroshi; Ikeda, Hisami; Ikebuchi, Kenji; Takeoka, Shinji; Tsuchida, Eishun; Harashima, Hideyoshi.

    In: Artificial Cells, Blood Substitutes, and Biotechnology, Vol. 34, No. 1, 01.04.2006, p. 1-10.

    Research output: Contribution to journalArticle

    Abe, Hideki ; Fujihara, Mitsuhiro ; Azuma, Hiroshi ; Ikeda, Hisami ; Ikebuchi, Kenji ; Takeoka, Shinji ; Tsuchida, Eishun ; Harashima, Hideyoshi. / Interaction of hemoglobin vesicles, a cellular-type artificial oxygen carrier, with human plasma : Effects on coagulation, kallikrein-kinin, and complement systems. In: Artificial Cells, Blood Substitutes, and Biotechnology. 2006 ; Vol. 34, No. 1. pp. 1-10.
    @article{c838285d7b4d4390a3c00e8d1279e9c3,
    title = "Interaction of hemoglobin vesicles, a cellular-type artificial oxygen carrier, with human plasma: Effects on coagulation, kallikrein-kinin, and complement systems",
    abstract = "Hemoglobin vesicles (HbVs), cellular-type artificial oxygen carriers containing human hemoglobin, were assessed for their biocompatibility by mixing with human plasma in vitro. Among three kinds of HbVs (PEG-DPEA-HbV, PEG-DPPG-HbV and DPPG-HbV), PEG-DPEA-HbV did not affect the extrinsic or intrinsic coagulation activities of the plasma, while PEG-DPPG-HbV and DPPG-HbV tended to shorten the intrinsic coagulation time. The kallikrein-kinin cascade of the plasma was slightly activated by PEG-DPPG-HbV and DPPG-HbV, but not by PEG-DPEA-HbV. The complement consumption of the plasma was observed by incubation with DPPG-HbV, but not with PEG-DPEA-HbV or PEG-DPPG-HbV. These results indicate that PEG-DPEA-HbV has a higher biocompatibility with human plasma.",
    keywords = "Complement, Hemoglobin vesicles, Kallikrein-Kinin, Liposome, Oxygen carrier",
    author = "Hideki Abe and Mitsuhiro Fujihara and Hiroshi Azuma and Hisami Ikeda and Kenji Ikebuchi and Shinji Takeoka and Eishun Tsuchida and Hideyoshi Harashima",
    year = "2006",
    month = "4",
    day = "1",
    doi = "10.1080/00207450500428204",
    language = "English",
    volume = "34",
    pages = "1--10",
    journal = "Artificial Cells, Nanomedicine and Biotechnology",
    issn = "2169-1401",
    publisher = "Informa Healthcare",
    number = "1",

    }

    TY - JOUR

    T1 - Interaction of hemoglobin vesicles, a cellular-type artificial oxygen carrier, with human plasma

    T2 - Effects on coagulation, kallikrein-kinin, and complement systems

    AU - Abe, Hideki

    AU - Fujihara, Mitsuhiro

    AU - Azuma, Hiroshi

    AU - Ikeda, Hisami

    AU - Ikebuchi, Kenji

    AU - Takeoka, Shinji

    AU - Tsuchida, Eishun

    AU - Harashima, Hideyoshi

    PY - 2006/4/1

    Y1 - 2006/4/1

    N2 - Hemoglobin vesicles (HbVs), cellular-type artificial oxygen carriers containing human hemoglobin, were assessed for their biocompatibility by mixing with human plasma in vitro. Among three kinds of HbVs (PEG-DPEA-HbV, PEG-DPPG-HbV and DPPG-HbV), PEG-DPEA-HbV did not affect the extrinsic or intrinsic coagulation activities of the plasma, while PEG-DPPG-HbV and DPPG-HbV tended to shorten the intrinsic coagulation time. The kallikrein-kinin cascade of the plasma was slightly activated by PEG-DPPG-HbV and DPPG-HbV, but not by PEG-DPEA-HbV. The complement consumption of the plasma was observed by incubation with DPPG-HbV, but not with PEG-DPEA-HbV or PEG-DPPG-HbV. These results indicate that PEG-DPEA-HbV has a higher biocompatibility with human plasma.

    AB - Hemoglobin vesicles (HbVs), cellular-type artificial oxygen carriers containing human hemoglobin, were assessed for their biocompatibility by mixing with human plasma in vitro. Among three kinds of HbVs (PEG-DPEA-HbV, PEG-DPPG-HbV and DPPG-HbV), PEG-DPEA-HbV did not affect the extrinsic or intrinsic coagulation activities of the plasma, while PEG-DPPG-HbV and DPPG-HbV tended to shorten the intrinsic coagulation time. The kallikrein-kinin cascade of the plasma was slightly activated by PEG-DPPG-HbV and DPPG-HbV, but not by PEG-DPEA-HbV. The complement consumption of the plasma was observed by incubation with DPPG-HbV, but not with PEG-DPEA-HbV or PEG-DPPG-HbV. These results indicate that PEG-DPEA-HbV has a higher biocompatibility with human plasma.

    KW - Complement

    KW - Hemoglobin vesicles

    KW - Kallikrein-Kinin

    KW - Liposome

    KW - Oxygen carrier

    UR - http://www.scopus.com/inward/record.url?scp=31144450037&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=31144450037&partnerID=8YFLogxK

    U2 - 10.1080/00207450500428204

    DO - 10.1080/00207450500428204

    M3 - Article

    VL - 34

    SP - 1

    EP - 10

    JO - Artificial Cells, Nanomedicine and Biotechnology

    JF - Artificial Cells, Nanomedicine and Biotechnology

    SN - 2169-1401

    IS - 1

    ER -